Overview
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system in which the immune system attacks the myelin sheath surrounding nerve fibres in the brain and spinal cord, disrupting nerve signalling. The resulting demyelination and inflammation produce a wide and variable range of neurological symptoms, including fatigue, sensory disturbances, visual and motor impairments, and cognitive changes, which may follow relapsing-remitting or progressive courses. MS is among the most common causes of non-traumatic neurological disability in young adults, and its unpredictable nature poses substantial physical, psychological, and social challenges. Key areas of study include the underlying immunology and the biology of oligodendrocytes and myelin repair, disease-modifying and symptomatic therapies, rehabilitation, and the management of comorbidities and environmental influences such as vitamin D and ultraviolet exposure. The journal publishes peer-reviewed research and related disorders reflecting these themes, including studies on pediatric MS presentation, neurovascular reactivity after relapses, evidence-based occupational therapy for rehabilitation, ultraviolet B phototherapy trials, disability and prognostic factors in cohort studies, COVID-19 vaccine safety in people with MS, coping strategies during the pandemic, and oligodendrocyte development and Wnt signalling. Differential diagnoses such as acute disseminated encephalomyelitis (ADEM) are also addressed.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Neurovascular Reactivity after Repeated Attacks in Patients with Multiple Sclerosis
Safety of BBIBP-CorV (Sinopharm) COVID-19 Vaccination in People With Multiple Sclerosis: A Report From Iran
Ultraviolet B Phototherapy Intervention in Patients with Multiple Sclerosis: A Prospective, Randomized Pilot Trial
Fragiles but Resilient. The Key Strategies to Cope with Pandemic in Persons with Multiple Sclerosis. A Controlled Web Survey
Characterization of the Consciousness Energy Healing Treated Cholecalciferol Using LC-MS and GC-MS Spectrometry
Disability and prognostic factors of MS severity: An Algerian cohort study
Post-Covid-19 Acute Disseminated Encephalomyelitis (ADEM) in a 27-year-old girl: Case Report
The Early Use of Blinding in Therapeutic Clinical Research of Neurological Disorders
Why Music in Neurology?
Oligodendrocytes Development and Wnt Signaling Pathway
How this research is being cited
The 12 articles above have been cited 38 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Photochemical & Photobiological Sciences
-
2026 · Cells
-
2026 · Molecular Psychiatry
-
2025 · Photochemical & Photobiological Sciences
-
Uwe Riedmann et al. · 2025 · Photochemical and Photobiological Sciences
-
2025 · bioRxiv (Cold Spring Harbor Laboratory)
-
2025 · Genome Biology
-
2024 · Pharmaceuticals
A sample of recent works citing this journal's research on Multiple Sclerosis, linking to each citing work.